Cargando…
In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-mediated coronavirus disease 2019 (COVID-19) infection remains a global pandemic and health emergency with overwhelming social and economic impacts throughout the world. Therapeutics for COVID-19 are limited to only remdesivir; therefo...
Autores principales: | Lawal, Bashir, Tsai, Sheng-Kuang, Wu, Alexander T.H., Huang, Hsu-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904858/ https://www.ncbi.nlm.nih.gov/pubmed/36777994 http://dx.doi.org/10.1016/j.arabjc.2023.104654 |
Ejemplares similares
-
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
por: Shamim, Khalida, et al.
Publicado: (2021) -
In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)—amentoflavone as a multitarget candidate
por: Portilla-Martínez, Andrés, et al.
Publicado: (2022) -
Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
por: Huang, Xiaoling, et al.
Publicado: (2023) -
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
por: Mahmud, Shafi, et al.
Publicado: (2021) -
The current state of validated small molecules inhibiting SARS-CoV-2 nonstructural proteins
por: KOCABAŞ, Fatih, et al.
Publicado: (2021)